Intracardiac Echocardiography for Point-of-Care Guided Left Ventricular Assist Device Implantation: Surgical Implications for COVID-19

Konstantin Yastrebov; Laurencie Brunel; Hugh S Paterson; Zoe A Williams; Innes K Wise; Christopher S Burrows; Paul G Bannon

doi:10.1177/15533506211037787

Intracardiac Echocardiography for Point-of-Care Guided Left Ventricular Assist Device Implantation: Surgical Implications for COVID-19

Surg Innov. 2022 Apr;29(2):292-294. doi: 10.1177/15533506211037787. Epub 2021 Aug 8.

Authors

Konstantin Yastrebov^{1

2}, Laurencie Brunel¹, Hugh S Paterson¹, Zoe A Williams¹, Innes K Wise¹, Christopher S Burrows¹, Paul G Bannon^{1

3

4}

Affiliations

¹ Sydney Imaging, Core Research Facility, 522555The University of Sydney, Sydney, NSW, Australia.
² 6804Prince of Wales Hospital and The University of New South Wales, Sydney, NSW, Australia.
³ The Baird Institute of Applied Heart and Lung Surgical Research, Sydney, NSW, Australia.
⁴ Institute of Academic Surgery, 2205Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia.

Abstract

Data from animal models is now available to initiate assessment of human safety and feasibility of wide-angle three-dimensional intracardiac echocardiography (3D ICE) to guide point-of-care implantation of percutaneous left ventricular assist devices in critical care settings. Assessment of these combined new technologies could be best achieved within a surgical institution with pre-existing expertise in separate utilization of ICE and Impella.

Keywords: COVID-19; Impella; intracardiac echocardiography; left ventricular assist device.

MeSH terms

Animals
COVID-19*
Echocardiography / methods
Heart-Assist Devices*
Point-of-Care Systems
Thoracic Surgical Procedures*
Treatment Outcome